World's Best Scientists 2026 revealed!
Award Badge
Immunology
UK
2026
Award Badge
Medicine
UK
2026

D-Index & Metrics

Immunology

D-Index
157
Citations
95289
World Ranking
94
National Ranking
7

Medicine

D-Index
158
Citations
95809
World Ranking
850
National Ranking
90

Adrian V. S. Hill publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Adrian V. S. Hill sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 727 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Adrian V. S. Hill D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Adrian V. S. Hill sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 157 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United Kingdom Leader Award
  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Immunology in United Kingdom Leader Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award
  • 2022 - Research.com Immunology in United Kingdom Leader Award

Overview

Adrian V. S. Hill is affiliated with the University of Oxford in the United Kingdom. Their research predominantly focuses on the fields of Medicine and Immunology and Microbiology. Within these fields, their work extends into several specialized subfields, including Infectious Diseases, Public Health, Environmental and Occupational Health, Immunology, Molecular Biology, and Epidemiology.

Their main research topics cover a range of areas related to infectious disease control and immune response mechanisms. These topics include Malaria Research and Control, SARS-CoV-2 and COVID-19 Research, Mosquito-borne Diseases and Control, Vaccines and Immunoinformatics Approaches, COVID-19 Clinical Research Studies, Immunotherapy and Immune Responses, and Viral Infections and Outbreaks Research.

The scientist has contributed to numerous research publications, frequently collaborating with several co-authors. Notable frequent co-authors include Katie Ewer, Alexander J. Mentzer, Sarah C. Gilbert, Andrew J. Pollard, and Pedro M. Folegatti.

Adrian V. S. Hill has published extensively in several scientific venues. The most frequent venues are bioRxiv (Cold Spring Harbor Laboratory), Zenodo (CERN European Organization for Nuclear Research), Frontiers in Immunology, SSRN Electronic Journal, and The Lancet.

Significant recent papers include:

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, 2020, The Lancet
  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial, 2020, The Lancet
  • Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection, 2021, Nature Medicine
  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials, 2021, The Lancet
  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial, 2021, The Lancet

Best Publications

  • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

    Paul R. Burton;David G. Clayton;Lon R. Cardon;Nick Craddock

  • Common West African HLA antigens are associated with protection from severe malaria

    Adrian V. S. Hill;Catherine E. M. Allsopp;Dominic Kwiatkowski;Nicholas M. Anstey

  • Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

    William McGuire;Adrian V. S. Hill;Catherine E. M. Allsopp;Brian M. Greenwood

  • Genome-wide association study identifies eight loci associated with blood pressure

    Christopher Newton-Cheh;Christopher Newton-Cheh;Toby Johnson;Toby Johnson;Vesela Gateva;Martin D. Tobin

  • Erratum: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

    A D Douglas;A R Williams;J J Illingworth;G Kamuyu

  • Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

    Paul R Burton;David G Clayton;Lon R Cardon;Nick Craddock

  • TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

    D. Kwiatkowski;A. V. S. Hill;I. Sambou;P. Twumasi

  • Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans.

    Richard Bellamy;Cyril Ruwende;Tumani Corrah;Keith P.W.J. McAdam

  • Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls

    Nick Craddock;Matthew E. Hurles;Niall Cardin;Richard D. Pearson

  • Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

    Jörg Schneider;Sarah C. Gilbert;Tom J. Blanchard;Tomas Hanke

  • Rapid Effector Function in CD8+ Memory T Cells

    Ajit Lalvani;Roger Brookes;Sophie Hambleton;Warwick J. Britton

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Pedro M Folegatti;Katie J Ewer;Parvinder K Aley;Brian Angus

  • Molecular analysis of the association of HLA-B53 and resistance to severe malaria.

    A V Hill;J Elvin;A C Willis;M Aidoo

  • THE IMMUNOGENETICS OF HUMAN INFECTIOUS DISEASES

    Adrian V. S. Hill

  • Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study

    Emma E Davenport;Katie L Burnham;Jayachandran Radhakrishnan;Peter Humburg

  • Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

    Helen McShane;Ansar A Pathan;Clare R Sander;Sheila M Keating

  • Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.

    Ajit Lalvani;Ansar A. Pathan;Helen McSHANE;Robert J. Wilkinson

  • Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

    Samuel J McConkey;William H H Reece;Vasee S Moorthy;Daniel Webster

  • In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

    Robert P. Anderson;Pilar Degano;Andrew J. Godkin;Derek P. Jewell

  • Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

    Sergey Nejentsev;Joanna M. M. Howson;Neil M. Walker;Jeffrey Szeszko

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Katie J. Ewer
Katie J. Ewer University of Oxford
Simon J. Draper
Simon J. Draper University of Oxford
Helen McShane
Helen McShane University of Oxford
Philip Bejon
Philip Bejon University of Oxford
Ian D. Poulton
Ian D. Poulton University of Oxford
Dominic P. Kwiatkowski
Dominic P. Kwiatkowski University of Oxford
Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II
Kevin Marsh
Kevin Marsh University of Oxford
Robert E. Sinden
Robert E. Sinden Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, related healthcare degrees offer diverse career paths that complement this field. Many quickly transition to advanced roles through accelerated NP programs online, which provide an efficient route to becoming a Nurse Practitioner with a strong foundation in patient immunological care.

Those without a nursing background can explore online ABSN programs for non nurses. These programs are designed to fast-track non-nursing students into the nursing profession, enabling them to gain critical clinical skills relevant to immunology and infection control.

Finding the right program is crucial, especially when considering prerequisites and admission difficulty. For example, students may look into the easiest ABSN program to get into to begin a career quickly while maintaining strong academic support.

Moreover, entry-level pathways like Licensed Practical Nurse programs are popular starting points. Individuals often seek out which LPN programs are easiest to get into to enter the healthcare workforce promptly, gaining valuable experience applicable in immunology-related settings.

Best Scientists Citing Adrian V. S. Hill

Trending Scientists

Recently Published Articles